A 26-year-old primigravida at 33 weeks asks about RSV prevention for her newborn. What is true about maternal RSV vaccination and infant monoclonal antibody?ABoth should be routinely given to maximise protectionBEither maternal RSV vaccine at 32-36 weeks or infant nirsevimab is recommended; both are not routinely given togetherCOnly nirsevimab is recommended; maternal vaccination is contraindicatedDVaccination must be at 28-30 weeks to be effectiveEGive palivizumab to all infants regardless of riskCheck my answer